Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sebia logo — A Global specialized In Vitro Diagnostic player

Sebia

A Global specialized In Vitro Diagnostic player

Founded 1967 France France 555 employees Private Equity Biotechnology, Health Care

General Information

Company Name Sebia
Founded Year 1967
Location France France
Employees 555
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Sebia. To contact Sebia, visit sebia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sebia compare?

A PDF of Sebia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sebia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sebia

Sebia is a global leader in the specialty In Vitro Diagnostic industry, focusing on screening and monitoring diseases in areas such as Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmunity, and other rare pathologies. The company was founded in 1967 and is headquartered in the South of Paris, France. Sebia's mission is to provide powerful tools that can interpret what is happening in a patient's body, effectively establishing a new language of life. The company is known for setting high standards in technologies, scientific excellence, and manufacturing capabilities, allowing it to continuously advance and maintain an exciting pipeline of new tests and automated equipment. Moreover, Sebia secured a Private Equity Round investment on 11th August 2017, with the funding coming from Caisse de Depot et Placement du Quebec. The company operates in the Biotechnology and Health Care industries, showcasing a lasting commitment to making a meaningful impact in the field of healthcare diagnostics.

Business keywords: In Vitro Diagnostics, Oncology, Diabetes, Hemoglobinopathy, Autoimmunity, Rare Pathologies, Clinical Protein Electrophoresis, Diagnostic Solutions, Automated Equipment, Medical Diagnostics, Laboratory Diagnostics, Capillary Electrophoresis, Gel Electrophoresis, ELISA, Mass Spectrometry

Services & Products

Provision of diagnostic equipment
tests
software
and educational resources for healthcare professionals in the field of metabolic and autoimmune diseases.

Target Customers

Healthcare professionals clinical laboratories medical researchers and healthcare institutions worldwide.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Caisse de Depot et Placement du Quebec
11 Aug 2017
Private Equity Round Undisclosed 3
HarbourVest Partners Montagu
HarbourVest Partners, Montagu +1
03 Jun 2014

Sebia Alternatives & Competitors

Sebia vs
CGC Genetics / CGC Centro Genetica Clinica
CGC Genetics / CGC Centro Genetica Clinica

For over two decades, CGC Genetics has been a leading provider of specialty genetic tests and has gr...

Private Equity
56 employees
Biotechnology, Health Care
Sebia vs
Anagnostics
Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs i...

Venture round
Biotechnology, Health Care
Sebia vs
Roche
Roche Switzerland

A healthy Sweden, where all knowledge is put to use.

106762 employees
Biotechnology, Health Care

FAQ About Sebia

A Global specialized In Vitro Diagnostic player
Sebia was founded in 1967.
Sebia is headquartered in France.
Sebia operates in Biotechnology and Health Care. Its work centres on In Vitro Diagnostics, Oncology, Diabetes and Hemoglobinopathy. Its customers include Healthcare professionals, clinical laboratories and medical researchers.
Sebia has approximately 555 employees.
Sebia has completed 2 funding rounds. The latest funding stage is Private Equity.
Sebia offers: Provision of diagnostic equipment, tests, software, and educational resources for healthcare professionals in the field of metabolic and autoimmune diseases..
Top alternatives and competitors to Sebia include CGC Genetics / CGC Centro Genetica Clinica, Anagnostics, Roche, Fujirebio, Intuitive Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sebia and CGC Genetics / CGC Centro Genetica Clinica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sebia, https://bouncewatch.com/company/sebia, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes